GAIN THERAPEUTICS, INC Cash and Cash Equivalents
GAIN THERAPEUTICS, INC (GANX) had Cash and Cash Equivalents of $13.08 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-11
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $13.08M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $16.54M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $20.84M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $8.81M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $13.08M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $16.54M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $20.84M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $8.81M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $6.69M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $9.07M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $10.39M 10-K · filed 2026-03-26 |
| 2024-09-30 | $12.05M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $16.94M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $10.64M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $11.79M 10-K · filed 2025-03-27 |
| 2023-09-30 | $4.27M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $6.32M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.99M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $7.31M 10-K · filed 2024-03-26 |
| 2022-09-30 | $10.88M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $14.31M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $34.34M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $36.88M 10-K · filed 2023-03-23 |
| 2021-09-30 | $40.98M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $43.16M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $46.59M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $7.49M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |